MaxCyte, Inc. - Common Stock (NQ:MXCT)

1.100 +0.030 (+2.80%)

Delayed Quote Updated: 2:28 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MaxCyte, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs

January 23, 2024

Imugene using MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support azer-cel – a potential first-in-class allogeneic CD19 CAR T product candidate for the treatment of blood cancer...

From MaxCyte, Inc

Via GlobeNewswire

Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday ↗

January 09, 2024

U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday.

Via Benzinga

Topics Stocks

Recap: MaxCyte Q3 Earnings ↗

November 08, 2023

Via Benzinga

Why Cell Engineering Company MaxCyte Shares Are Up Today ↗

January 09, 2024

MaxCyte Inc (NASDAQ: MXCT) shares are trading higher by over 9% after the company disclosed strong preliminary Q4 and full-year

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 08, 2024

Via Benzinga

MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results

January 08, 2024

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte and Lion TCR form Partnership to Support Global Expansion of Lion TCR's TCR-T Cell Pipeline

January 03, 2024

Lion TCR to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to develop and scale TCR-T cell therapies for solid tumors and viral-related diseases.

From MaxCyte, Inc; Lion TCR

Via GlobeNewswire

MaxCyte Confirms Appointment of Maher Masoud as President, Chief Executive Officer and Director

January 02, 2024

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023

December 11, 2023

From MaxCyte, Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 06, 2023

Via Benzinga

MaxCyte Joins the Alliance for mRNA Medicines (AMM) as a Founding Member

November 16, 2023

MaxCyte continues supporting the advancement of novel therapeutics and looks to support education and advancement of mRNA medicines

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte Reports Third Quarter 2023 Financial Results and Reiterates Full Year 2023 Revenue Guidance

November 08, 2023

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte to Participate in Two Upcoming Investor Conferences

November 06, 2023

From MaxCyte, Inc

Via GlobeNewswire

Cell Engineering MaxCyte Faces Challenge, Analysts Express Concerns Over Near-Term Prospects Amid Revenue Decline ↗

October 05, 2023

MaxCyte Inc (NASDAQ: MXCT) shares plummeted after the company released preliminary Q3 revenue of $7.8 million – 8.0 million, a Y/Y decrease of 25 -27%, due to continued reduced

Via Benzinga

Crude Oil Down 2%; ConAgra Brands Earnings Top Views ↗

October 05, 2023

U.S. stocks traded slightly lower toward the end of trading, with the Dow Jones index falling around 40 points on Thursday. The Dow traded down 0.12% to 33,088.44 while the NASDAQ fell 0.23% to...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 05, 2023

Via Benzinga

Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

October 05, 2023

Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent...

Via Benzinga

Why Shares of MaxCyte Are Plummeting on Thursday ↗

October 05, 2023

The biotech company reduced full-year guidance and expects so-so third-quarter revenue.

Via The Motley Fool

Dow Tumbles Over 100 Points; Constellation Brands Raises Profit Forecast ↗

October 05, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.45% to 32,980.31 while the NASDAQ fell 0.62% to 13,154.24. The...

Via Benzinga

Topics Stocks

BB Stock Alert: What to Know as BlackBerry Plans IPO for IoT Division ↗

October 05, 2023

BlackBerry stock is a hot topic among BB shareholders today alongside news the company is considering an IPO for its IoT business.

Via InvestorPlace

Topics Initial Public Offering

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 05, 2023

Via Benzinga

Why Is MaxCyte (MXCT) Stock Down 21% Today? ↗

October 05, 2023

MaxCyte stock is taking a beating on Thursday as investors in MXCT shares react to preliminary results for its third quarter of 2023.

Via InvestorPlace

Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket ↗

October 05, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

October 05, 2023

Pre-market stock movers are rising and falling on Thursday as we check out all of the latest news worth knowing about this morning!

Via InvestorPlace

MaxCyte, Rivian Automotive And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

October 05, 2023

U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Conagra Brands, Constellation Brands And 3 Stocks To Watch Heading Into Thursday ↗

October 05, 2023

With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 04, 2023

Via Benzinga

MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance

October 04, 2023

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing

September 06, 2023

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte to Participate in Baird Global Healthcare Conference

September 05, 2023

From MaxCyte, Inc

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.